TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
From 11 May 2017, American Depository Receipts (ADRs) in Statoil (OSE: STL, NYSE: STO) listed on the New York Stock Exchange will be traded ex-dividend USD 0.2201 and ex rights to participate in the dividend issue (scrip dividend programme) for fourth quarter 2016.
From 12 May 2017, the shares in Statoil at Oslo Stock Exchange (Oslo Børs) will be traded ex dividend USD 0.2201 and ex rights to participate in the dividend issue (scrip dividend programme) for fourth quarter 2016.
Record date at New York Stock Exchange and Oslo Børs is 15 May 2017.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
